Ribotype | Number of isolates | Toxinotype | Toxin genes |
---|---|---|---|
Patient rooms: | (n = 14) |  |  |
 078a | 64.3% (9) | V | tcdA, tcdB, cdtA |
 MOH-AIb | 21.4% (3) | 0 | tcdA, tcdB |
 027c | 7.1% (1) | III | tcdA, tcdB, cdtA |
 MOH-Vc | 7.1% (1) | 0 | tcdA, tcdB |
General environment: | (n = 14) |  |  |
 078 | 35.7% (5) | V | tcdA, tcdB, cdtA |
 027 | 14.3% (2) | III | tcdA, tcdB, cdtA |
 MOH-V | 14.3% (2) | 0 | tcdA, tcdB |
 001 | 7.1% (1) | 0 | tcdA, tcdB |
 MOH-AG | 7.1% (1) | 0 | tcdA, tcdB |
 MOH-T | 7.1% (1) | 0 | tcdA, tcdB |
 MOH-U | 7.1% (1) | 0 | tcdA, tcdB |
 UNK-2 | 7.1% (1) | Not tested | None |
Patientsd: | (n = 21) |  |  |
 027e | 33.3% (7) | III | tcdA, tcdB, cdtA |
 MOH-C | 14.3% (3) | IX | tcdA, tcdB, cdtA |
 CHP-Af | 9.5% (2) | XXIV | tcdA, tcdB, cdtA |
 MOH-AD | 9.5% (2) | III | tcdA, tcdB, cdtA |
 078 | 4.8% (1) | V | tcdA, tcdB, cdtA |
 CHP-C | 4.8% (1) | XXIV | tcdA, tcdB, cdtA |
 CHP-D | 4.8% (1) | 0 | tcdA, tcdB |
 MOH-M | 4.8% (1) | 0 | tcdA, tcdB |
 MOH-Q | 4.8% (1) | XII | tcdA, tcdB |
 MOH-V | 4.8% (1) | 0 | tcdA, tcdB |
 MOH-Y | 4.8% (1) | III | tcdA, tcdB, cdtA |